Abstract
Tetrahydrocurcumin (THC) is a major metabolite of curcumin, which is obtained from Curcuma longa. THC has various benefits and overcomes the bioavailability issue of curcumin. To establish it as a pharmacologically active molecule, its safety profile has to be determined. Thus, the present study aimed to determine the preclinical safety profile of THC in a 90-day subchronic and reproductive/developmental toxicity study in Wistar rats. THC at oral doses of 100, 200, and 400 mg/kg was administered daily for 90 days. Rats in the recovery group were kept for 14 days after treatment termination. The animals were observed for treatment-related morbidity, mortality, and changes in clinical signs, clinical pathology, and histopathology. In the reproductive/developmental toxicity study, THC at 100, 200, and 400 mg/kg was administered orally to rats and the reproductive/developmental parameters in adult male and female rats and pups were observed. THC at up to 400 mg/kg/day of did not have any significant effect on all parameters in male and female rats in both toxicity studies. Thus, 400 mg/kg/day can be considered as the no-observed-adverse-effect-level of THC in rats.
Article PDF
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs00204-016-1811-y/MediaObjects/204_2016_1811_Fig1_HTML.gif)
Avoid common mistakes on your manuscript.
References
Pandey, A., Gupta, R.K. and Srivasta, R. (2011) Curcumin - the yellow magic. Asian J. Appl. Sci., 4, 343–354.
Stankovic, I. (2004) Curcumin, Chemical and Technical Assessment (CTA). 61st JECFA, FAO.
Prasad, S. and Aggarwal, B.B. (2011) Chapter 13. Turmeric, the golden spice: from traditional medicine to modern medicine in Herbal Medicine: Biomolecular and Clinical Aspects (2nd edition) (Benzie, I.F.F. and Wachtel-Galor, S., Eds.). CRC Press/Taylor & Francis, Boca Raton. Available from: http://www.ncbi.nlm.nih.gov/books/NBK92752/.
Pawar, H., Karde, M., Mundle, N., Jadhav, P. and Mehra, K. (2014) Phytochemical evaluation and curcumin content determination of turmeric rhizomes collected from Bhandara District of Maharashtra (India). Med. Chem., 4, 588–591.
Chattopadhyay, I., Biswas, K., Bandyopadhyay, U. and Banerjee, R. (2004) Turmeric and curcumin: biological actions and medicinal applications. Current Sci., 87, 44–53.
National Center for Biotechnology Information (2005) Tetrahydrodiferuloylmethane. PubChem Compound Database, CID: 124072 [accessed 2018 Jan 5]. Available from: http://pubchem.ncbi.nlm.nih.gov/compound/.
Manjunatha, J.R. and Srinivas, P. (2015) Synthesis of Water Soluble Curcumin Derivatives and Evaluation of Their Bioactive and Anti Amyloid Aggregating Properties. University of Mysore, Sodhaganga. Available from: http://hdl.handle.net/10603/102621/.
Majeed, M., Pineda, R., Chan, G., Gabriel, T., Dayrit, J., Pelayo, C.A. and Prakash, L. (2010) A randomized, doubleblind, placebo-controlled, comparative study The safety and efficacy of 0.25% tetrahydrocurcumin (turmeric) cream as depigment agent against 4% hydroquinone cream. H&PC Today, 3, 44–46.
Randino, R., Grimaldi, M., Persico, M., Santis, A.D., Cini, E., Cabri, W., Riva, A., D’Errico, G., Fattorusso, C., D’Ursi, A.M. and Rodriquez, M. (2016) Investigating the neuroprotective effects of turmeric extract: structural interactions of β-amyloid peptide with single curcuminoids. Sci. Rep., 6, 38846.
Hassaninasab, A., Hashimoto, Y., Tomita-Yokotani, K. and Kobayashi, M. (2011) Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. PNAS, 108, 6615–6620.
Vijaya Saradhi, U.V., Ling, Y., Wang, J., Chiu, M., Schwartz, E.B., Fuchs, J. R., Chan, K.K. and Liu, Z. (2010) A liquid chromatography-tandem mass spectrometric method for quantification of Curcuminoids in cell medium and mouse plasma. J. Chromatogr. B, 878, 3045–3051.
Aggarwal, B.B., Deb, L. and Prasad, S. (2015) Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules, 20, 185–205.
Pan, M.S., Huang, T.M. and Lin, J.K. (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos., 27, 486–494.
Vijayan, D., Tintu, I. and Sadasivan, C. (2011) Molecular docking studies of curcumin analogs with phospholipase A2. Interdiscip. Sci. Comput. Life Sci., 3, 189–197.
Somparn, P., Phisalaphong, C., Nakornchai, S., Unchern, S. and Morales, N.P. (2007) Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharm. Bull., 30, 74–78.
Mukhopadhyay, A., Basu, N., Ghatak, N. and Gujral, P.K. (1982) Anti-inflammatory and irritant activities of curcumin analogs in rats. Agents Actions, 12, 508–515.
Murugan, P. and Pari, L. (2007) Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. J. Ethnopharmacol., 113, 479–486.
Pari, L. and Murugan, P. (2007) Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Renal Fail., 29, 881–889.
Nakmareong, S., Kukongviriyapan, U., Pakdeechote, P., Donpunha, W., Kukongviriyapan, V., Kongyingyoes, B., Sompamit, K. and Phisalaphong, C. (2011) Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch. Pharmacol., 383, 519–529.
Pari, L. and Murugan, P. (2007) Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin-nicotinamide-induced type 2 diabetes. Fund. Clin. Pharmacol., 21, 665–671.
Sugiyama, Y., Kawakishi, S. and Osawa, T. (1996) Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol., 52, 519–525.
Khopde, S.M., Priyadarsini, K.I., Guha, S.N., Satav, J.G., Venkatesan, P. and Rao, M.N. (2000) Inhibition of radiationinduced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci. Biotechnol. Biochem., 64, 503–509.
Okada, K., Wangpoengtrakul, C., Tanaka, T., Toyokuni, S., Uchida, K. and Osawa, T. (2001) Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J. Nutr., 131, 2090–2095.
Naito, M., Wu, X., Nomura, H., Kodama, M., Kato, Y., Kato, Y. and Osawa, T. (2002). The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J. Atheroscler. Thromb., 9, 243–250.
Lai, C.S., Wu, J.C., Yu, S.F., Badmaev, V., Nagabhushanam, K., Ho, C.T. and Pan M.H. (2011) Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethaneinduced colon carcinogenesis. Mol. Nutr. Food Res., 55, 1819–1828.
Tsai, M.-L., Tsai, S.-P. and Ho, C.-T. (2017) Tetrahydrocurcumin attenuates carbon tetrachloride-induced hepatic fibrogenesis by inhibiting the activation and autophagy of hepatic stellate cells. J. Funct. Foods, 36, 418–428.
Wu, J.-C., Lai, C.-S., Badmaev, V., Nagabhushanam, K., Ho, C.T. and Pan, M.H. (2011) Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol. Nutr. Food Res., 55, 1646–1654.
Majeed, M., Pande, A., Paliwal, P. and Nagabhushanam, K. (2012) Tetrahydrocurcuminoids. NutriScience Publishers.
Kroes, R., Garbis-Berkvens, J.M., de Vries, T. and van Nesselrooy, J.H.J. (1981) Histopathological profile of a Wistar rat stock including a survey of the literature. J. Gerontol., 36, 259–279.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Majeed, M., Natarajan, S., Pandey, A. et al. Subchronic and Reproductive/Developmental Toxicity Studies of Tetrahydrocurcumin in Rats. Toxicol Res. 35, 65–74 (2019). https://doi.org/10.5487/TR.2019.35.1.065
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2019.35.1.065